ストックスクリーナーアプリを入手
52.49
4.42%
-2.43
アフターアワーズ：
52.52
0.03
+0.06%
前日終値:
$54.92
開ける：
$54.11
24時間の取引高:
1.37M
Relative Volume:
0.91
時価総額：
$3.22B
収益：
$362.27M
当期純損益:
$-85.19M
株価収益率:
-36.20
EPS:
-1.45
ネットキャッシュフロー:
$-68.71M
1週間 パフォーマンス:
+10.13%
1か月 パフォーマンス:
+26.76%
6か月 パフォーマンス:
+90.32%
1年 パフォーマンス:
+9.40%
1日の値動き範囲:
$51.82
$54.39
1週間の範囲:
$47.62
$57.88
52週間の値動き範囲:
$23.30
$57.88
Twist Bioscience Corp Stock (TWST) Company Profile
名前
Twist Bioscience Corp
セクター
電話
800-719-0671
住所
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
52.49 | 3.37B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
515.12 | 192.95B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
211.25 | 147.43B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
630.73 | 50.70B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
126.34 | 35.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
328.66 | 32.13B | 3.17B | 642.63M | 539.81M | 10.77 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-04 | 開始されました | Stephens | Overweight |
| 2024-12-13 | 開始されました | Wolfe Research | Outperform |
| 2024-06-04 | 開始されました | Guggenheim | Buy |
| 2024-01-17 | アップグレード | Goldman | Neutral → Buy |
| 2023-09-27 | 開始されました | Berenberg | Buy |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2023-01-03 | アップグレード | Evercore ISI | In-line → Outperform |
| 2022-03-02 | 再開されました | Cowen | Outperform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-29 | 開始されました | William Blair | Outperform |
| 2021-06-04 | 開始されました | Goldman | Neutral |
| 2021-04-12 | 開始されました | Piper Sandler | Overweight |
| 2021-02-05 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2020-10-20 | 開始されました | SVB Leerink | Mkt Perform |
| 2019-05-31 | 開始されました | Evercore ISI | Outperform |
| 2018-11-26 | 開始されました | JP Morgan | Neutral |
すべてを表示
Twist Bioscience Corp (TWST) 最新ニュース
Twist Bioscience Corp (TWST) Trading Down 4.44% on Feb 19 - GuruFocus
Biotech CEO and CFO face investor questions at three March conferences - Stock Titan
Twist Bioscience stock hits 52-week high at $51.02 - Investing.com India
Twist Bioscience Raises FY26 Revenue Forecast Exceeding Market Expectations - StocksToTrade
Twist Bioscience stock hits 52-week high at $51.02 By Investing.com - Investing.com South Africa
Twist Bioscience licenses Invenra’s bispecific antibody platform - Investing.com
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement - Business Wire
Insider Sell: Adam Laponis Sells 7,000 Shares of Twist Bioscience Corp (TWST) - GuruFocus
Twist Bioscience (NASDAQ:TWST) Insider Dennis Cho Sells 5,000 Shares - MarketBeat
Twist Bioscience Corporation (NASDAQ:TWST) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes - Business Wire
Twist Bioscience (NASDAQ:TWST) Director Sells $105,402.00 in Stock - MarketBeat
Twist Bioscience Annual Meeting: Shareholders Elect Directors, Approve Pay and EY Auditor Ratification - Yahoo Finance
Twist Bioscience shareholders approve director elections and executive compensation - Investing.com
Twist Bioscience shareholders approve director elections and executive compensation By Investing.com - Investing.com Australia
Twist Bioscience Shareholders Back Directors and Governance Items - TipRanks
Twist Bioscience (NASDAQ:TWST) CEO Emily Leproust Sells 5,001 Shares of Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) CAO Robert Werner Sells 7,000 Shares - MarketBeat
Twist Bioscience (TWST) Valuation After Q1 Beat And Raised 2026 Outlook - simplywall.st
Commit To Purchase Twist Bioscience At $37.50, Earn 27.6% Annualized Using Options - Nasdaq
Twist Bioscience Guidance Lift Puts AI Demand And Risks In Focus - Yahoo Finance
Assessing Twist Bioscience (TWST) Valuation After Recent Share Price Momentum - Yahoo Finance
Decoding Twist Bioscience Corp (TWST): A Strategic SWOT Insight - GuruFocus
6 Analysts Assess Twist Bioscience: What You Need To Know - Benzinga
TWST: Evercore ISI Group Raises Price Target on Twist Bioscience - GuruFocus
Barclays Raises Price Target for Twist Bioscience (TWST) to $50 - GuruFocus
These Analysts Increase Their Forecasts On Twist Bioscience After Q1 Results - Benzinga
Twist Bioscience Corporation $TWST Stake Raised by Thrivent Financial for Lutherans - MarketBeat
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript - Insider Monkey
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - ChartMill
Twist Bioscience Corporation (TWST): A Bull Case Theory - Finviz
Twist Bioscience Corp SEC 10-Q Report - TradingView
Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Twist Bioscience Q1 2026 slides: Revenue beats guidance, path to profitability accelerates By Investing.com - Investing.com South Africa
Why Is Twist Bioscience Stock Soaring Monday? - Benzinga
Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Highlights: S - GuruFocus
Twist Bioscience (NASDAQ:TWST) Shares Gap UpStill a Buy? - MarketBeat
Twist Bioscience (TWST) Stock Surges Over 12% - GuruFocus
Twist Bioscience stock jumps as record quarterly revenue lifts 2026 outlook — what investors watch next - TechStock²
Twist Bioscience (TWST) Boosts Revenue Forecast, Shares Rise - GuruFocus
Twist Bioscience earnings missed by $0.07, revenue topped estimates - Investing.com Canada
Earnings call transcript: Twist Bioscience Q1 2026 sees revenue growth, stock surges - Investing.com India
Twist Bioscience Stock Climbs 7% Over Narrower Loss In Q1 - Nasdaq
Twist Bioscience Q1 2026 Earnings Call Transcript - AOL.com
Twist Bioscience (TWST) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
TWIST BIOSCIENCE CORP (NASDAQ:TWST) Reports Mixed Q1 FY2026 Results with Revenue Beat and Wider Loss - ChartMill
Twist Bioscience (TWST) Surpasses Revenue Expectations in Q1 - GuruFocus
Twist Bioscience (TWST) Reports Q1 Revenue Beat, EPS Miss - GuruFocus
TWST Reports Impressive Revenue Growth in Latest Financial Update - GuruFocus
Twist Bioscience: Fiscal Q1 Earnings Snapshot - KVUE
Twist Bioscience (TWST) Raises Revenue Forecast for 2026 - GuruFocus
Twist Bioscience Corp (TWST) 財務データ
収益
当期純利益
現金流量
EPS
0.95%
1.33%
大文字化:
|
ボリューム (24 時間):